Industries · Pharmaceutical
Pharmaceutical Industry
Remove complex redesign, re-engineering & revalidation.
Reducing procurement and validation time & costs
Driving Factors
- Disconnected data silos limiting AI-readiness.
- Pressure to deploy AI into GMP environments.
- A requirement for more flexible systems.
- A need for resilient, sustainable operations.
End User Requirements
- Connected digital operations & AI-readiness.
Adaptive Solution
- Modular production architecture creates standardised, vendor-independent equipment interfaces.
- Provides standardised data layers without bespoke vendor integrations.
Modular drug development — modular labs — modular manufacturing
Driving Factors
- Speed to market has become a major competitive factor.
- Growing opportunities for low-volume, high-mix and complex formats.
End User Requirements
- Adaptable manufacturing for new modalities.
- More efficient lab processes, pilot and scale manufacturing.
Adaptive Solution
- Standardised modular cells provide the "digital thread".
- Enables multi-product setups and scalable processing.
Operational efficiency without compliance compromise
The Pressure
- Serialisation and aggregation hardware retrofits are causing measurable OEE losses on pharmaceutical packaging lines.
End User Requirements
- Reliable, standardised data across all KPIs.
- Batch-level granularity for sustainability reporting.
Adaptive Solution
- A single data architecture addressing both compliance audits and sustainability reporting.
Bring modularity to your GMP environment
Let's design a validated, vendor-independent architecture around your products and lines.
Get in touch